RAPID POINT OF CARE DIAGNOSTICS FOR HCV
$299,957N43FY2021AINIH
Phoenix Biosystem, Inc., Pleasanton CA
Investigators
Abstract
To develop rapid, point-of-care diagnostics for Hepatitis C Virus (HCV).
View original record on NIH RePORTER →Phoenix Biosystem, Inc., Pleasanton CA
To develop rapid, point-of-care diagnostics for Hepatitis C Virus (HCV).
View original record on NIH RePORTER →